1403 Outcomes following first-line immunotherapy with or without chemotherapy stratified by KRAS mutational status – A real world analysis in patients with advanced NSCLC | Zendy

AI Assistant Blog Pricing

1403 Outcomes following first-line immunotherapy with or without chemotherapy stratified by KRAS mutational status – A real world analysis in patients with advanced NSCLC

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.